Our news and insights
17 April 2026
Awareness
EHC marks World Haemophilia Day 2026 with a Letter to the Future
As part of its ongoing Living Well, Ageing Well project, the EHC is launching a series of initiatives that place the lived experience of ageing with a bleeding disorder at the centre of the conversation.
22 December 2025
News
Statement on Severe Adverse Event in Marstacimab Clinical Trial
Pfizer has announced the death of a participant enrolled in the long-term open-label extension study (B7841007) of marstacimab in individuals with haemophilia A or B, with or without inhibitors.
16 January 2026
News
New EHC comprehensive guide to von Willebrand Disease (VWD) now available
This new resource provides clear, accessible information on key topics for anyone seeking to better understand VWD, including symptoms, diagnosis, testing methods, treatment options, menstrual health and more.
Stay up-to-date with the latest EHC activities and events!